📰 William Bonello News
Page 3 - William Bonello News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from William Bonello. Real-time updates on events, politics, business and more.
March 29, 2022
NeoGenomics (NASDAQ:NEO – Get Rating) had its target price cut by research analysts at BTIG Research from $35.00 to $28.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. BTIG Research’s target price would suggest a potential upside of 57.39% from the company’s […]
March 28, 2022
Board Appoints Executive Chair and Interim Office of the CEOAnticipates First Quarter Results Below Guidance and Withdraws 2022 GuidanceFT. MYERS, FL / ACCESSWIRE / March 28, 2022 / NeoGenomics, Inc. (NASDAQ:NEO)
March 28, 2022
$ million. The larger than anticipated EBITDA loss was primarily driven by higher than anticipated Clinical Services cost of goods sold. The Company intends to take immediate action to address... | March 28, 2022
March 28, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
March 15, 2022
Two Sigma Advisers LP acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 7,000 shares of the medical research company’s stock, valued at approximately $338,000. Other hedge funds have also recently bought and sold […]
March 10, 2022
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) CFO William Bonello sold 3,209 shares of the company’s stock in a transaction dated Monday, March 7th. The shares were sold at an average price of $18.29, for a total transaction of $58,692.61. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can […]
November 4, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation.
May 5, 2021
Neogenomics Inc (NEO) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neogenomics Inc (NASDAQ: NEO) Operator Good morning, ladies and gentlemen, and welcome to the NeoGenomics First Quarter 2021 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Doug Vianor. Sir, the floor is yours.SPONSORED: 10 stocks we like better than NeoGenomics, Inc. When investing geniu...